TG THERAPEUTICS, INC. Debt Instrument, Interest Rate, Stated Percentage
TG THERAPEUTICS, INC. (TGTX) had Debt Instrument, Interest Rate, Stated Percentage of 8.95% as of 2023-03-31, per its 10-Q filed 2023-08-04.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2023-08-04
- 2023-03-31: Debt Instrument, Interest Rate, Stated Percentage 8.95%.
- 2013-09-30: Debt Instrument, Interest Rate, Stated Percentage 5.00%.
- 2013-06-30: Debt Instrument, Interest Rate, Stated Percentage 5.00%.
- 2013-03-31: Debt Instrument, Interest Rate, Stated Percentage 5.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2023-03-31 | 8.95% 10-Q · filed 2023-08-04 |
| 2013-09-30 | 5.00% 10-Q · filed 2013-11-14 |
| 2013-06-30 | 5.00% 10-Q · filed 2013-08-09 |
| 2013-03-31 | 5.00% 10-Q · filed 2013-05-14 |
| 2012-12-31 | 5.00% 10-K · filed 2013-03-21 |
| 2012-09-30 | 5.00% 10-Q · filed 2012-11-14 |
| 2012-06-30 | 5.00% 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |